Literature DB >> 7251446

Effect of severe hypoxia on the pulmonary vascular response to vasoconstrictor agents.

A L Harabin, M D Peake, J T Sylvester.   

Abstract

When isolated blood-perfused pig lungs are exposed to inspired O2 tensions (PIO2) below 30 Torr, hypoxic pulmonary vasoconstriction is transient. To determine whether this transience is caused by a decrease in the amount of ATP available for maintenance of smooth muscle contraction, we compared normoxic (PIO2 = 100 Torr) and hypoxic (PIO2 = 10 Torr) dose-response curves to infusions of prostaglandin F2 alpha (PGF2 alpha), angiotensin II (AII), and potassium chloride (KCl). Hypoxia caused reversible depression of the responses to PGF2 alpha and AII but had no effect on the response to KCl. Because during hypoxia the lung was capable of an undiminished vasoconstrictor response to at least one agent, it seems unlikely that the supply of ATP available for contraction was limiting. The mechanism for the transience of the vasoconstrictor response to low PO2 values and the depression of the response to AII and PGF2 alpha remains unknown, but could involve depression of ATP production sufficient to limit some energy-requiring process other than contraction or release of a vasodilator.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251446     DOI: 10.1152/jappl.1981.50.3.561

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

1.  Differences in the hypoxic contraction of small isolated pulmonary arteries of cat and rabbit.

Authors:  P Bonnet; J A Argibay; E White; D Garnier
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

2.  ATP-dependent K+ channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs.

Authors:  C M Wiener; A Dunn; J T Sylvester
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 3.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.